Idexx Laboratories | IDXX - Ebitda

Aktienkurs
560.11
Täglich Wechseln
-12.09 -2.11%
Monatlich
-4.21%
Jährlich
13.91%
Q2 Prognose
548.52




Ebitda Veränderung Datum
Abbott USD 3.27B 178M 2025-12
Accuray USD -685K 900K 2024-09
Align Technology USD 260.87M 77.03M 2025-12
AngioDynamics USD 5.94M 3.78M 2025-09
Dentsply International USD 129M 6M 2026-03
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Fujifilm JPY 132.72B 8.92B 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
Henry Schein USD 289M 2M 2026-03
Idexx Laboratories USD 354.91M 36.56M 2025-12
Insulet USD 181.7M 12.3M 2026-03
Integra LifeSciences USD 76.18M 28.03M 2026-03
Intuitive Surgical USD 1.09B 165.5M 2025-12
Masimo USD 91.9M 19.9M 2025-09
Neogen USD 48.2M 546K 2025-12
Orthofix International USD 27.88M 2.77M 2025-12
Phibro Animal Health USD 68.1M 6.2M 2025-12
ResMed USD 547.48M 27.46M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Steris USD 389.7M 22.5M 2025-09
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teleflex USD 247.07M 575.88M 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Zoetis USD 939M 101M 2025-12